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Anemia is a clinical manifestation with high prevalence in the world, reaching about 30% of the total inhabitants of the planet. It
is responsible for a great reduction in quality of life of aﬀected people. The present paper aimed to obtain the frequency of anemia
in the blood counts of a sample from the population of registered patients of a Family Health Team in Dourados, MS, Brazil. 462
patients, who had blood counts done from February 2008 to March 2009, were included in this research. The frequency of anemia
was 22.7% in the studied population, including all age groups.
1.Introduction
Anemia is a common ﬁnding in the world population, aﬀect-
ing both developing countries and industrialized nations.
It reaches about 2 billion people worldwide, or about 30%
of the total inhabitants of the planet, according to data
from the World Health Organization-WHO. Because of
such magnitude, it is considered a public health problem.
It can greatly aﬀect a person’s life, especially in its more
severe forms. Anemia causes tiredness, weakness, malaise,
and making routine tasks more diﬃcult and painful [1]. The
aﬀected person may be drowsy, with less resistance to phys-
ical activities and deterioration in cognitive function and
immunity [2]. A drop in libido may occur [1]. Thus, quality
of life can be seriously injured. Nutritional lack of iron leads
to the most frequent type of anemia, iron deﬁciency anemia.
Even motor development in children can be disturbed by
iron deﬁciency [3–5], but this nutritional privation has easy
and inexpensive care and prophylaxis. Thus, government
or personal expenses to reverse its eﬀects or avoid iron
deﬁciency anemia are not large and can bring great improve-
ments to the lives of individuals. In the staﬀ’s routine of the
Family Health Strategy studied in Dourados, MS, Brazil, it
can be seen that anemia aﬀects a lot of patients. Therefore,
a study about the frequency of that clinical manifestation
can provide greatinformation forthe planning of prevention
and treatment. The aim of this research was to obtain the
frequency of anemia in blood counts of those patients.
2. Methods
A quantitative and descriptive study, with a retrospective
component, using secondary data and blood counts from
the medical records of patients subjected to research, was
conducted in the city of Dourados, MS, Brazil. Patients
ascribed to the Family Health Strategy studied totalize 4,244
people and a purposive sample of 462 patients from that
population was used. The sample consists of patients who
attended the Health Unit and had blood counts done during
the period from February 2008 to March 2009. Pregnant
patients were excluded. Data were collected through forms
made by the author containing information on sex, age,
and hematologic condition of the research subjects. Results
were organized into charts and tables with descriptive
statistical analysis through Software Excel 2007 and Epi-Info
3.3.2. This research was authorized by Committee of Stage,
Practical Class, Research and/or Final Course Work from
the Municipal Health Department–CEPET, and it was also2 Anemia
approved by Ethics Committee on Human Research from
Federal University of Mato Grosso do Sul-UFMS, according
to Ordinance MS 196/96, protocol number 1497. Rules for
use of information from patients’ records are mentioned in
items III.3.i and III.3.t of Resolution CNS 196/96 and they
were followed. The present research did not entail risks to
patients, since the blood samples had already been collected.
It beneﬁts population, since, from the determination of
frequency of anemia, prevention and treatment actions can
be made.
3. Results
3.1. General Frequency of Anemia. The frequency of anemia
obtained in the studied sample was 22,7%, including all age
groups.
3.2. Frequency of Anemia by Age. The frequency of anemia
by age in the studied sample is shown in Figure 1.A m o n g
the teenagers from 12 to 15 years old, 64.3% were anemic.
Among children aged 1 year, this occurrence was 57.1%, and
in those aged 2–5 years, it was 56%. Anemia was found in
52.1%ofchildr enfr om6to12y ears.Inchildr enunder1y ear
in the sample, 30.8% were anemic, while 13.8% of people
aged16yearsormoreshowedthesameclinicalmanifestation
at the time of collecting their blood counts. The oldest
patient was 92 years old.
Tables 1 and 2 show the values of hemoglobin and
the hematocrit found in the sample studied in relation to
age range. Table 3 correlates the MCV (Mean Corpuscular
Volume) values in relation to age range. Among children
younger than 1 year, the most common hemoglobin values
varied from 11.0 to 12.4g/dL (or g%), the range in which
53.8% of those patients were in (Table 1). The most frequent
hematocrit values in the same patients were between 36 and
40.9%, a range spanning 38.5% of those children (Table 2).
In patients aged from 1 to 15 years old and older than
15 years old, the most common hemoglobin values were
between 12.5 and 13.9g/dL, observed in 41.1% and 38.1%
of those populations, respectively (Table 1), while their most
frequent hematocrit ranged between 36 and 40.9%, values
found in 64.2% and 41% of those populations, respectively
(Table 2). The hemoglobin and hematocrit found have
meaning only if analyzed at the individual level, since they
vary according to each age. Such analysis was subject of
Figure 1.
Table 3 shows that the most frequent values of Mean
Corpuscular Volume (MCV) among children under 1 year
old varied from 80 to 84.9µ3, which are the values found in
46.2%ofthosepatients,whileboththepopulationagedfrom
1t o1 5y e a r so l da n da g e do v e r1 5y e a r so l ds h o w e dm o s t
frequent MCV values between 85 and 89.9µ3. Those values
were observed in 52.6% of patients aged from 1 to 15 years
old and in 50.0% of patients over 15 years old.
The Mean Corpuscular Hemoglobin (MCH) values in
61.6% of patients younger than 1 year old were between 25
and 28.9ng—30.8% of them with values between 25 and
26.9ng and other 30.8% with values between 27 and 28.9ng.
It was observed that 45.3% of patients aged from 1 to 15
years old had values of MCH between 27 and 28.9ng, while
71.8% of patients over age 15 had MCH values between 29
and 30.9ng (Table 4).
Table 5 discriminates the values of Mean Corpuscular
Hemoglobin Concentration (MCHC) that were found in
each age. It is observed that in all age groups the most
frequentMCHCvaluesrangedfrom32to33.9%.Suchvalues
were found in 69.2% of patients younger than 1 year old,
83.2% of patients aged from 1 to 15 years old and 91.5% of
patients over 15 years old.
Children under 1 year old have diﬀerent reference values
for hemoglobin, hematocrit, MCV, MCH, and MCHC,
according to age. Figure 1 was constructed by analyzing
each child individually. In tables, they were grouped into
denomination “younger than 1 year old” to easy viewing.
Table 6 shows the reference values for each parameter
(erythrocytes, hemoglobin, hematocrit, MCV, MCH, and
MCHC) according to age.
4. Discussion
The anemia frequency found in nearly 23% in population
is high and it approaches those values found in the world:
about 30% of its population were aﬀected by anemia [6].
Such clinical manifestation can aﬀect quality of life by
decreasing exercise tolerance, impairing learning ability,
aﬀecting libido, causing fatigue, discomfort, and reducing
appetite among other changes. Thus, over 20% of people
who attended the Family Health Strategy team and who
were included in this research face damage in their ability to
perform daily activities, because of a blood disorder that can
be easily avoided and also easily reversed once installed.
The presence of infectious processes in children and
adolescents when blood counts were collected may have lead
to a bias in the results, possibly overestimating frequency of
real anemia, since a transient anemia can be found during an
infectious process.
A n e m i a sd on o ts p a r em o r ea ﬄuent social classes. And
the high number of anemia cases found in the study
population proves what is observed throughout the country:
anemias are the most prominent endemic deﬁciency, over-
coming the lack of iodine (which is currently under control),
vitamin A, and even protein-calorie malnutrition [7].
After treatment in the population of our study, based on
ferroussulfate,itwaspossibletoreversemostcasesofanemia
found. So iron deﬁciency anemia is supposed to be the most
prevalent type of this clinical manifestation in those people.
The values of Mean Corpuscular Volume, Mean Corpuscular
Hemoglobin, and Mean Corpuscular Hemoglobin Concen-
tration are needed if analyzed individually correlated with
the values of hemoglobin (Hb) and hematocrit (Ht) for each
patient studied and combined with additional laboratory
tests, not available in records analyzed. Such analysis may be
the object of further researches.
It can be seen in this study that the sample has prevalence
of women: 62.6% of patients (95% CI 58.0 to 67.0). This
is due to historical characterization that women are the







































Figure 1: Frequency of anemia in users of the Family Health Strategy studied, according to age range, from February 2008 to March 2009,
Dourados, MS, Brazil.
Table 1: Hemoglobin values according to age range, Dourados, MS, Brazil, 2009.
Hemoglobin values (g/dL or g%)∗ Younger than 1 year old From 1 to 15 years old Older than 15 years old
N % N % N %
6.5–7.9 1 7.7 — — 1 0.3
8.0–9.4 2 15.4 2 2.1 2 0.6
9.5–10.9 3 23.1 14 14.7 12 3.4
11.0–12.4 7 53.8 36 37.9 63 17.8
12.5–13.9 — — 39 41.1 135 38.1
14.0–15.4 — — 3 3.2 115 32.5
15.5–16.9 — — 1 1.1 24 6.8
17.0–18.4 — — — — 2 0.6
Total 13 100 95 100 354 100
∗g/dL: grams per deciliter of blood.
Table 2: Hematocrit values according to age range, Dourados, MS, Brazil, 2009.
Hematocrit values (%) Younger than 1 year old From 1 to 15 years old Older than 15 years old
N % N % N %
21–25.9 1 7.7 — — 3 0.8
26–30.9 3 23.1 3 3.2 4 1.1
31–35.9 4 30.8 24 25.3 28 7.9
36–40.9 5 38.5 61 64.2 145 41.0
41–45.9 — — 6 6.3 135 38.1
46–50.9 — — — — 37 10.5
51–55.9 — — 1 1.1 2 0.6
Total 13 100 95 100 354 1004 Anemia
Table 3: Mean Corpuscular Volume (MCV) values according to age range, Dourados/MS, Brazil, 2009.
MCV values (µ3) Younger than 1 year old From 1 to 15 years old Older than 15 years old
N % N % N %
50–55 — — — — 1 0.3
55–60 — — — — — —
60–65 1 7.7 1 1.1 1 0.3
65–70 — — 1 1.1 3 0.8
70–75 3 23.1 4 4.2 1 0.3
75–80 2 15.4 11 11.6 2 0.6
80–85 6 46.2 17 17.9 18 5.1
85–90 — — 50 52.6 177 50.0
90–95 1 7.7 11 11.6 149 42.1
95–100 — — — — 2 0.6
Total 13 100 95 100 354 100
Table 4: Mean Corpuscular Hemoglobin (MCH) values according to age range, Dourados/MS, Brazil, 2009.
MCH Values (ng) Younger than 1 year old From 1 to 15 years old Older than 15 years old
N % N % N %
15–16.9 — — 1 1.1 1 0.3
17–18.9 — — — — — —
19–20.9 1 7.7 — — 1 0.3
21–22.9 1 7.7 3 3.2 3 0.8
23–24.9 3 23.1 3 3.2 1 0.3
25–26.9 4 30.8 14 14.7 5 1.4
27–28.9 4 30.8 43 45.3 65 18.4
29–30.9 — — 30 31.6 254 71.8
31–32.9 — — 1 1.1 21 5.9
33–34.9 — — — — 3 0.8
Total 13 100 95 100 354 100
The values of hemoglobin and hematocrit found in
patients with anemia in the study population characterize
that clinical manifestation as mild in most cases and in all
ages. There were few cases of moderate to severe anemia,
whichrespondedpromptlytotherapywithoralorparenteral
replacement of iron, being characterized, although the lack
of additional laboratory tests available, as iron deﬁciency
anemia, because of its rapid response to treatment. The
WHO deﬁnes mild, moderate, and severe anemia according
to hemoglobin values. Mild anemia is characterized by
hemoglobin values between 11.0 and 11.9mg/dL in children
and adult women and between 12 and 12.9mg/dL in adult
men. Moderate anemia occurs when hemoglobin values vary
f r o m8 . 0t o1 0 . 9i nc h i l d r e na n da d u l tw o m e n ,a n df r o m
9.0 to 11.9 in adult men, and severe anemia has hemoglobin
values from 5.0 to 7.9 in children and adult women and from
6.0 to 8.9 in adult men.
The ﬁndings of the present research are similar to those
observed throughout Brazil, where anemia reaches about
50% of children between 6 months and 2 years old [6]a n d
between 40 and 50% of children under 5 years old [7].
T h ei r o nf o r t i ﬁ c a t i o ni nw i d e l yc o n s u m e df o o d si ne a c h
population was sustained as a measure of greater scope
to try reducing such a high prevalence of anemia. Several
studies show that food fortiﬁcation can reduce nutritional
deﬁciencies [8]. The supply of iron supplementation for
the most vulnerable population groups (such as children,
women at reproductive age, and pregnant women), food
fortiﬁcation, educational measures, and information to the
population are strategies for combating anemia. If added
together, they can be eﬀective in ﬁghting this serious public
health problem all over the world [7].
5. Conclusions
The high frequency of anemia in the study population
follows what can be seen worldwide. This clinical manifes-
tation does not discriminate between rich or poor countries
and aﬀects a great number of people in several nations. A
person’s life can be greatly disturbed by its symptoms, such
as tiredness, lower immunity, impairment in the growth
of children, in cognitive functions, and libido [1, 2]. Lack
of iron is a very common nutritional deﬁciency and it is
responsible for the most frequent type of anemia in the
world,theirondeﬁciencyanemia[5].Thetreatmentinthose
cases is simple and inexpensive, and so is its prevention.Anemia 5
Table 5: Mean Corpuscular Hemoglobin Concentration (MCHC) values according to age range, Dourados, MS, 2009.
MCHC values (%) Younger than 1 year old From 1 to 15 years old Older than 15 years old
N % N % N %
26–27.9 — — 1 1.1 1 0.3
28–29.9 — — — — 2 0.6
30–31.9 3 23.1 7 7.4 9 2.5
32–33.9 9 69.2 79 83.2 324 91.5
34–35.9 1 7.7 8 8.4 17 4.8
36–37.9 — — — — 1 0.3
Total 13 100 95 100 354 100
Table 6: Reference values for erythrocytes, hemoglobin, hematocrit, MCV, MCH, and MCHC according to age. Source: Clinical Laboratory,
University Hospital of Dourados, MS, Brazil. Brazilian Association of Hematology and Hemotherapy—(ABHH).
Age Hemoglobin (g/dL) Hematocrit (%) MCV (u3) MCH (ng) MCHC (%)
5 days 19-20 60–65 92–99 30–40 32–36
14 days 12.5–15.7 42–48 60–70 25–30 27–34
2 months 14–19 40–50 90–97 28–33 31–34
6 months 9.5–13.5 29–41 74–99 25–35 30–36
12 months 11.8–12.6 35–40 75–80 25–30 33–37
4 years 12.3–13.8 35–40 75–80 28–30 33–37
8 years 12.3–14 38–42 75–85 28–30 33–37
14 years 13.5–14.5 40–50 82–92 28–30 32–36
Adult men 14–16 40–54 82–92 27–32 32–36
Adult women 11–14 37–47 82–92 27–32 32–36
Avoiding or treating anemia can contribute to a higher
quality of life for people.
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